Effects of TGF-betas and a specific antagonist on apoptosis of immature rat male germ cells in vitro

Apoptosis

Volumn 11, Issue 5, 2006, Pages 739-748

  Konrad, L ^a,b   Keilani, M M ^a   Laible, L ^a   Nottelmann, U ^a   Hofmann, R ^a  

^a Medical Faculty   (Germany)

^b Department of Urology ^*  (Germany)

Author keywords

Antagonists; Apoptosis; Germ cells; Testis; TGF 1 3

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; LATENCY ASSOCIATED PEPTIDE; RECOMBINANT LATENCY ASSOCIATED PEPTIDE AGAINST TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; GERM CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PUBERTY; SPERMATOCYTE; SPERMATOGONIUM;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; MALE; ORGAN CULTURE TECHNIQUES; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; SPERMATOCYTES; SPERMATOGONIA; TESTIS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

MAMMALIA;

EID: 33745033828     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-5542-z     Document Type: Article

References (45)

1. de Caestecker M. The transforming growth factor-β superfamily of receptors. Cytokine Growth Factor Rev 2004; 15: 1-11.
2. Newfeld SJ, Wisotzkey RG, Kumar S. Molecular evolution of a developmental pathway: Phylogenetic analyses of transforming growth factor-β family ligands, receptors and Smad signal transducers. Genetics 1999; 152: 783-795.
3. Dubois CM, Blanchette F, Laprise MH, Leduc R, Grondin F, Seidah NG. Evidence that furin is an authentic transforming growth factor-β1- converting enzyme. Am J Pathol 2001; 158: 305-316.
4. Hyytiainen M, Penttinen C, Keski-Oja J. Latent TGF-β binding proteins: Extracellular matrix association and roles in TGF-β activation. Crit Rev Clin Lab Sci 2004; 41: 233-264.
5. Murphy-Ullrich JE, Poczatek M. Activation of latent TGF-β by thrombospondin-1: Mechanisms and physiology. Cytokine Growth Factor Rev 2000; 11: 59-69.
6. ten Dijke P, Hill CS. New insights into TGF-β-Smad signalling. Trends Biochem Sci 2004; 29: 265-273.
7. Rotzer D, Roth M, Lutz M, Lindemann D, Sebald W, Knaus P. Type III TGF-β receptor-independent signalling of TGF-β2 via TβRII-B, an alternatively spliced TGF-β type II receptor. EMBO J 2001; 20: 480-490.
8. Schuster N, Krieglstein K. Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res 2002; 307: 1-14.
9. Newmeyer DD, Ferguson-Miller S. Mitochondria: Releasing power for life and unleashing the machineries of death. Cell 2003; 112: 481-490.
10. Danial NN, Korsmeyer SJ. Cell death: Critical control points. Cell 2004; 116: 205-219.
11. Pentikainen V, Dunkel L, Erkkila K. Male germ cell apoptosis. Endocr Dev 2003; 5: 56-80.
12. Rodriguez I, Ody C, Araki K, Garcia I, Vassalli P. An early and massive wave of germinal cell apoptosis is required for the development of functional spermatogenesis. EMBO J 1997; 16: 2262-2270.
13. Shiratsuchi A, Umeda M, Ohba Y, Nakanishi Y. Recognition of phosphatidylserine on the surface of apototic spermatogenic cells and subsequent phagocytosis by Sertoli cells of the rat. J Biol Chem 1997; 272: 2354-2358.
14. Lui WY, Lee WM, Cheng CY. Transforming growth factor-β3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11. Endocrinology 2001; 142: 1865-1877.
15. Lui WY, Lee WM, Cheng CY. TGF-betas: Their role in testicular function and Sertoli cell tight junction dynamics. Int J Androl 2003; 26: 147-160.
16. Lui WY, Lee WM, Cheng CY. Transforming growth factor β3 regulates the dynamics of Sertoli cell tight junctions via the p38 mitogen-activated protein kinase pathway. Biol Reprod 2003; 68: 1597-1612.
17. Lui WY, Wong CH, Mruk DD, Cheng CY. TGF-β3 regulates the blood-testis barrier dynamics via the p38 mitogen activated protein (MAP) kinase pathway: an in vivo study. Endocrinology 2003; 144: 1139-1142.
18. Wong CH, Mruk DD, Lui WY, Cheng CY. Regulation of blood-testis barrier dynamics: an in vivo study. J Cell Sci 2004; 117: 783-798.
19. Yan W, Suominen J, Toppan J. Stem cell factor protects germ cells from apoptosis in vitro. J Cell Sci 2000; 113: 161-168.
20. Olaso R, Pairault C, Boulogne B, Durand P, Habert R. Transforming growth factor β1 and β2 reduce the number of gonocytes by increasing apoptosis. Endocrinology 1998; 139: 733-740.
21. Mullaney BP, Skinner MK. Transforming growth factor-beta (β1, β2, and β3) gene expression and action during pubertal development of the seminiferous tubule: potential role at the onset of spermatogenesis. Mol Endocrinol 1993; 7: 67-76.
22. Jahnukainen K, Chrysis D, Hou M, Parvinen M, Eksborg S, Soder O. Increased apoptosis occurring during the first wave of spermatogenesis is stage-specific and primarily affects midpachytene spermatocytes in the rat testis. Biol Reprod 2004; 70: 290-296.
23. Chipuk JE, Green DR. Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol 6: 268-275.
24. Bottinger EP, Factor VM, Tsang ML, et al. The recombinant proregion of transforming growth factor β1 (latency-associated peptide) inhibits active transforming growth factor β1 in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 5877-5882.
25. Koishi K, Dalzell KG, McLennan IS. The expression and structure of TGF-β2 transcripts in rat muscles. Biochim Biophys Acta 2004; 1492: 311-319.
26. Young GD, Murphy-Ullrich JE. Molecular interactions that confer latency to transforming growth factor-β. J Biol Chem 2004; 279: 38032-38039.
27. Billig H, Furuta I, Rivier C, Tapanainen J, Parvinen M, Hsueh AJ. Apoptosis in testis germ cells: developmental changes in gonadotropin dependence and localization to selective tubule stages. Endocrinology 1995; 136: 5-12.
28. Furuchi T, Masuko K, Nishimune Y, Obinata M, Matsui Y. Inhibition of testicular germ cell apoptosis and differentiation in mice misexpressing Bcl-2 in spermatogoma. Development 1996; 122: 1703-1709.
29. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ. Bax-dencient mice with lymphoid hyperplasia and male germ cell death. Science 1995; 270: 96-99.
30. Russell LD, Chiarini-Garcia H, Korsmeyer SJ, Knudson CM. Bax-dependent spermatogonia apoptosis is required for testicular development and spermatogenesis. Biol Reprod 2002; 66: 950-958.
31. Sinha Hikim AP, Lue Y, Diaz-Romero M, Yen PH, Wang C, Swerdloff RS. Deciphering the pathways of germ cell apoptosis in the testis. J Steroid Biochem Mol Biol 2003; 85: 175-182.
32. Narisawa S, Hecht NB, Goldberg E, Boatright KM, Reed JC, Millan JL. Testis-specific cytochrome c-null mice produce functional sperm but undergo early testicular atrophy. Mol Cell Biol 2002; 22: 5554-5562.
33. Honarpour N, Du C, Richardson JA, Hammer RE, Wang X, Herz J. Adult Apaf-1-deficient mice exhibit male infertility. Dev Biol 2000; 218: 248-258.
34. Freathy C, Brown DG, Roberts RA, Cain K. Transforming growth factor-β1 induces apoptosis in rat FaO hepatoma cells via cytochrome c release and oligomerization of Apaf-1 to form a approximately 700-kd apoptosome caspase-processing complex. Hepatology 2000; 32: 750-760.
35. Bedell MA, Mahakali Zama A. Genetic analysis of Kit ligand functions during mouse spermatogenesis. J Androl 2004; 25: 188-199.
36. Haagmans BL, Hoogerbrugge JW, Themmen AP, Teerds KJ. Rat testicular germ cells and Sertoli cells release different types of bioactive transforming growth factor beta in vitro. Reprod Biol Endocrinol 2003; 1: 3.
37. Konrad L, Keilani MM, Cordes A, et al. Rat Sertoli cells express epithelial but also mesenchymal genes after immortalization with SV40. Biochim Biophys Acta 2005; 1722: 6-14.
38. Konrad L, Albrecht M, Renneberg H, Aumuller G. Transforming growth factor-β2 mediates mesenchymal-epithelial interactions of testicular somatic cells. Endocrinology 2000; 141: 3679-3686.
39. Sanderson N, Factor V, Nagy P, et al. Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 1995; 92: 2572-2576.
40. Narula A, Kilen S, Ma E, Kroeger J, Goldberg E, Woodruff TK. Smad4 overexpression causes germ cell ablation and leydig cell hyperplasia in transgenic mice. Am J Pathol 2002; 161: 1723-1734.
41. Sanford LP, Ormsby I, Gittenberger-de Groot AC, et al. TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes. Development 1997; 124: 2659-2670.
42. Chang H, Brown CW, Matzuk MM. Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocr Rev 2002; 23: 787-823.
43. Kulkarni AB, Thyagarajan T, Letterio JJ. Function of cytokines within the TGF-β superfamily as determined from transgenic and gene knockout studies in mice. Curr Mol Med 2002; 2: 303-327.
44. Bhowmick MA, Chytil A, Plieth D, et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303: 848-851.
45. Stenvers KL, Tursky ML, Harder KW, et al. Heart and liver defects and reduced transforming growth factor β2 sensitivity in transforming growth factor β type III receptor-deficient embryos. Mol Cell Biol 2003; 23: 4371-4385.